Search

everythinglearnresearchcommunity

for

Search:↓

The study found that Central Centrifugal Cicatricial Alopecia mainly affects middle-aged African descent women, is linked to certain hair care practices and genetics, and often goes undiagnosed for years.

The antibody created from BCC tissues reacts similarly to both BCC and hair follicles, suggesting BCC may come from hair follicle cells.

Prednisone treatment helped a woman with Cronkhite-Canada syndrome recover from hair loss and digestive issues.

Regulatory T cells and mesenchymal stem cells work together to prevent immune system overreactions and tissue damage.

The QuantAnts machines can find cancer markers and create CRISPR targets for them.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Finasteride increases CD8+ T cells in BPH tissues.

Researchers created a mouse model for Cushing's syndrome to study glucocorticoid excess and potential treatments.

Certain immune cells may cause hair loss by reacting to stressed hair follicles.

Mutant stem cells adapt their metabolism differently to outcompete normal cells in the skin.

PRF lysates reduce inflammation in cancer cells and boost immune response in healthy oral cells.

Normal cells outcompete and remove mutant cells in the pancreas with the help of the EphA2 receptor.

Male-to-female skin grafts in mice are rejected due to sex-linked antigens.

CD2 might be a new treatment target for patchy alopecia areata.

The document concludes that computational models are useful for understanding immune responses and could improve cancer immunotherapy.

Sebaceous glands are often preserved and PPARy expression is constant in some cases of Central Centrifugal Cicatricial Alopecia.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Gamma delta T cells in the skin help with healing and defense but can also cause autoimmune issues, and more research is needed to understand how they are activated.

Activating TLR3 may help produce retinoic acid, important for tissue regeneration.

Deleting the MAD2L1 gene is tolerated in certain mouse cancer models.

FCER1A and RGS1 may help diagnose and treat systemic lupus erythematosus.

The type of tumor suppressor gene lost affects the behavior of skin cancer.

Spt4 and Spt6 are essential for fat cell development.

Polycomb Repressive Complex 1 is crucial for keeping stem cells stable and maintaining healthy adult tissues.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

The number of new cases of cutaneous B-cell lymphoma has leveled off since the early 2000s, and survival rates have improved since 1973.